Humana Inc. $HUM Shares Bought by American Century Companies Inc.

Key Points

• American Century Companies Inc. has increased its stake in Humana Inc. by 31.8%, now owning a total of 16,676 shares valued at approximately $4.4 million.
• Humana recently reported a quarterly earnings per share (EPS) of $6.27, which was slightly below the expected $6.32, despite having a revenue of $32.39 billion, exceeding analyst expectations.
• The company announced a quarterly dividend of $0.885 per share, reflecting an annualized dividend of $3.54 and a yield of 1.2%, with a payout ratio of 27.17%.

American Century Companies Inc. lifted its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 31.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 16,676 shares of the insurance provider's stock after acquiring an additional 4,021 shares during the period. American Century Companies Inc.'s holdings in Humana were worth $4,412,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in HUM. Revolve Wealth Partners LLC acquired a new stake in shares of Humana during the 4th quarter worth about $202,000. Solel Partners LP acquired a new position in Humana during the 4th quarter worth about $1,116,000. Accredited Wealth Management LLC purchased a new stake in Humana during the 4th quarter worth approximately $101,000. Aptus Capital Advisors LLC grew its stake in shares of Humana by 12.0% in the fourth quarter. Aptus Capital Advisors LLC now owns 859 shares of the insurance provider's stock worth $218,000 after acquiring an additional 92 shares in the last quarter. Finally, Cary Street Partners Financial LLC acquired a new stake in shares of Humana in the fourth quarter valued at $694,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have commented on HUM shares. Bank of America boosted their price target on shares of Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a report on Tuesday. Wall Street Zen downgraded Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Wells Fargo & Company reduced their price objective on shares of Humana from $348.00 to $344.00 and set an "overweight" rating for the company in a research report on Thursday, August 14th. Robert W. Baird cut their price target on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Finally, Barclays set a $275.00 price target on shares of Humana and gave the company an "equal weight" rating in a research report on Thursday, July 31st. Seven investment analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. According to MarketBeat.com, Humana has a consensus rating of "Hold" and a consensus price target of $285.76.

Humana Stock Performance

Shares of HUM stock traded up $3.09 during midday trading on Wednesday, hitting $313.15. The company had a trading volume of 813,553 shares, compared to its average volume of 1,700,515. The stock has a market cap of $37.66 billion, a price-to-earnings ratio of 24.00, a PEG ratio of 1.79 and a beta of 0.44. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The company's 50 day simple moving average is $257.24 and its 200 day simple moving average is $255.32. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $382.72.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The business's quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the business earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.1%. Humana's dividend payout ratio (DPR) is currently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.